TECH - Bio-Techne Corp logo

TECH

Bio-Techne Corp

Bio-Techne Corporation develops and sells life science reagents, instruments, and services for research, diagnostics, and bioprocessing, focusing on proteins, diagnostic assays, and genomics for academic, clinical, and pharmaceutical markets globally.

โš•๏ธ Healthcare NASDAQ Listed 1989 $ USD
$1,000 invested 30 years ago โ†’$49,670today

Score Overview

1 Year
Score
Net Growth49.28%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-0.72%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.7
Net Growth-21.96%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth30.05%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth4.88%
Net Trend50%
Net Income Consistency
Rev Growth142.64%
Rev Trend90%
Revenue Consistency
20 Years
Score5.4
Net Growth49.38%
Net Trend60%
Net Income Consistency
Rev Growth497.59%
Rev Trend90%
Revenue Consistency
30 Years
Score
Net Growth12x
Net Trend70%
Net Income Consistency
Rev Growth22x
Rev Trend93%
Revenue Consistency
All Time
Score
Net Growth273x
Net Trend76%
Net Income Consistency
Rev Growth96x
Rev Trend95%
Revenue Consistency

See the full market ranking โ†’

Bio-Techne Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 738M to $ 1.21B and net income declined from $ 229M to $ 73M. Revenue increased in 4 of those 5 years; net income in 3.

Across Bio-Techne Corp's full reported history, from 1989 to 2025, revenue grew from $ 12M to $ 1.21B and net income grew from $ 400K to $ 73M. Revenue increased in 95% of the years measured; net income in 76%.

Bio-Techne Corp currently holds a 20-year HDB Score of 5.4 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 72.23โ€”
1 Year2025-08-12
$ 52.5137.55%
5 Years2021-08-12
$ 112.97-36.06%
10 Years2016-08-12
$ 25.98178.00%
20 Years2006-08-11
$ 9.767x
30 Years1996-08-12
$ 1.4549x
All Time1989-02-09
$ 0.09794x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 1.21B$ 109M$ 209M
2025$ 1.21B$ 73M$ 162M
2024$ 1.15B$ 168M$ 152M
2023$ 1.13B$ 285M$ 204M
2022$ 1.10B$ 272M$ 247M
2021$ 931M$ 140M$ 231M
2020$ 738M$ 229M$ 270M
2019$ 714M$ 96M$ 166M
2018$ 642M$ 125M$ 181M
2017$ 563M$ 77M$ 157M
2016$ 499M$ 104M$ 95M
2015$ 452M$ 107M$ 110M
2014$ 357M$ 110M$ 363M
2013$ 310M$ 112M$ 332M
2012$ 314M$ 112M$ 268M
2011$ 289M$ 112M$ 140M
2010$ 269M$ 109M$ 138M
2009$ 263M$ 105M$ 202M
2008$ 257M$ 103M$ 206M
2007$ 223M$ 85M$ 164M
2006$ 202M$ 73M$ 108M
2005$ 178M$ 66M$ 97M
2004$ 161M$ 52M$ 176M
2003$ 145M$ 45M$ 117M
2002$ 130M$ 27M$ 97M
2001$ 115M$ 34M$ 97M
2000$ 103M$ 26M$ 59M
1999$ 90M$ 16M$ 29M
1998$ 67M$ 15M$ 27M
1997$ 60M$ 10M$ 8M
1996$ 54M$ 8M$ 7M
1995$ 47M$ 6M$ 5M
1994$ 40M$ 5M$ 5M
1993$ 28M$ 4M$ 4M
1992$ 22M$ 2M$ 4M
1991$ 19M$ 1M$ 2M
1990$ 15M$ 1M$ 1M
IPO1989$ 12M$ 400K$ 1M

Explore beyond TECH

You're looking at Bio-Techne Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies